Esperion Therapeutics, Inc. logo

Esperion Therapeutics, Inc.

NASDAQ:ESPR

Overview | Financials
Company Name Esperion Therapeutics, Inc.
Symbol ESPR
Currency USD
Price 2.48
Market Cap 422,636,640
Dividend Yield 0%
52-week-range 0.7 - 3.4
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Sheldon L. Koenig
Website https://www.esperion.com

An error occurred while fetching data.

About Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The

Related Stocks

Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc.

TYRA

18.72 USD

Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc.

GLUE

4.95 USD

Belite Bio, Inc logo

Belite Bio, Inc

BLTE

45.16 USD

Regencell Bioscience Holdings Limited logo

Regencell Bioscience Holdings Limited

RGC

5.06 USD

Arcellx, Inc. logo

Arcellx, Inc.

ACLX

54.36 USD

Inotiv, Inc. logo

Inotiv, Inc.

NOTV

1.84 USD

Kodiak Sciences Inc. logo

Kodiak Sciences Inc.

KOD

3.26 USD

MeiraGTx Holdings plc logo

MeiraGTx Holdings plc

MGTX

5.54 USD

Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc.

VRDN

13.53 USD

Financials

Numbers are in millions USD

Numbers are in millions USD